Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-23 Purchase | 2021-03-24 7:21 pm | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 100,000 | $2.4818 | $248,180 | 180,426 (Direct) | View |
| 2020-07-08 Purchase | 2020-07-10 6:11 pm | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 37,500 | $2.737 | $102,638 | 57,836 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-08 Option Award | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 37,567 | $0 | 278,242 (Direct) | View |
| 2021-12-08 Disposition | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 37,567 | $0 | 278,242 (Direct) | View |
| 2021-12-08 Tax Withholding | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 14,884 | $1.42 | 278,242 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:51 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 682,100 | $0 | 682,100 (Direct) | View |
| 2021-03-17 Option Award | 2021-03-19 4:55 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 22,590 | $0 | 80,426 (Direct) | View |
| 2021-03-17 Disposition | 2021-03-19 4:55 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 22,590 | $0 | 80,426 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 22,591 | $0 | 42,926 (Direct) | View |
| 2020-06-11 Disposition | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 22,591 | $0 | 42,926 (Direct) | View |
| 2020-06-11 Tax Withholding | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 9,755 | $3.09 | 42,926 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 8:59 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 281,800 | $0 | 281,800 (Direct) | View |